SELLAS Life Sciences Group (SLS) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.11
-0.09
-0.08
-0.06

Details

Expected EPS
-0.076667
Actual EPS
-0.06
Surprise EPS
0.02
Surprise Percent
+21.74%

Description

SELLAS Life Sciences Group (SLS) has reported earnings of -0.06 per share for Q4 2025.

0 Comments

Share your thoughts